Aha, I see, thanks. So, I guess then we will not see the

New Post Public Reply Private Reply Replies (0) Message Board
EliteYoda Wilyfox013 #2684

Aha, I see, thanks. So, I guess then we will not see the 10K for a while, possibly over a month from now. Trying to think of future catalysts we could see from now until then, possibly news on the new line of products and also marketing efforts and distributors. I think if by early October if we get the 10K that should really boost the stock because a greater number of investors could become shareholders after having access to see the inner workings of the company. I think just on discipline alone, many potential investors probably remain on the sidelines for a stock which has the yield sign and is not fully reporting, not to mention the trade for trade restriction. I think the major potential catalyst for the future is uplisting to the OTCBB. If that could be done by Nov elections or the end of the year, I think the volume could be much greater and the share price could go up because of the new interest in the stock and company. There is also the matter of the Q2 report, unless management intends to roll that into the 10K, however OTC markets site may soon downgrade the reporting status to the dreaded "STOP - No Information" sign if nothing else is submitted or filed within their reporting time constraints. While the business plan looks great and management has already brought shareholders value in terms of a growing company with products and sales, the corporate side of the action and change has yet to be verified via official filings. I think once those are made public we could see a big change in the stock. Until then there are still other PRs and news items which could be bullish for the stock.

As a shareholder I would though like to know exactly how many CannaCigs the company itself has in inventory and what the inventory situation is for all of the distributors to which we have ever sold. I have a feeling that the market is not properly valuing the worth of the inventory the company has on hand and the number of units already sold. Forgetting about every other valuation factor and just focusing on net worth of inventory and assuming basically zero debt or costs, about 2,000 CannaCigs alone, if sold, is worth about $200k and assuming a very low P/E of about 25, that comes to a share price of about $0.0045, not even close to the current stock price!!! And such a share price valuation only accounts for the worth of the immediate inventory, nothing else. With the company talking about 10,000 units for upcoming quarters, the profits alone could be close to $500k which alone would value the stock at about $0.011 at a very low P/E of 25. Hmmmmmm....

GLTA!

$RFMK!

Rapid Fire Marketing, Inc. (RFMK) Stock Research Links

RFMK Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

OnTime's Bold Vision: Transforming Home Healthcare Admin

Updated Category News Views 7

Changing the Game for Home Healthcare Every now and then, an idea rolls in that speaks to a real need, and OnTime's push to soften the burdens of the home healthcare industry might just be one of those. Built from grassroots experience, they're dropping efforts to modernize the back-end monotony so healthcare workers can zero in on, well, healthcare. A Nose-Dive into...

Continue Reading
Image Analysis Group Unveils DYNAMIKA V.7 for Clinical Trials

Updated Category News Views 185

Introduction to DYNAMIKA V.7 by Image Analysis Group Image Analysis Group (IAG) has recently launched DYNAMIKA V.7, an advanced cloud platform tailored for clinical trial imaging. Following stringent audits and certifications, including SOC II Type I compliance and British Standards Institute (BSI) surveillance audit certification, this platform stands out in its field....

Continue Reading
Sanofi's Strategic Move to Enhance Adult Vaccination Pipeline

Updated Category News Views 95

Sanofi Strengthens Its Vaccination Portfolio Sanofi SA (NASDAQ: SNY) has made a significant step in the healthcare sector by acquiring Dynavax Technologies Corporation (NASDAQ: DVAX) for approximately $2.2 billion. This acquisition, which involves a cash purchase price of $15.50 per share, signals Sanofi's commitment to enhancing its capabilities in the adult immunization...

Continue Reading
Miral Impact Fund: A New Era for Community and Environment

Updated Category News Views 135

Introducing the Miral Impact Fund Miral has taken a significant step towards environmental stewardship and social responsibility by launching the Miral Impact Fund. This initiative, launched in partnership with the Authority of Social Contribution – Ma'an, aims to create a positive impact within communities by addressing pressing social issues while promoting...

Continue Reading
Class Action Update for Regeneron Pharmaceuticals Investors

Updated Category News Views 125

Class Action Lawsuit Overview for Regeneron Pharmaceuticals Levi & Korsinsky, LLP has announced that Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) investors should take note of a pending class action lawsuit concerning alleged securities fraud. Understanding the Class Action The lawsuit aims to recover losses for investors adversely affected by claims of fraud that...

Continue Reading